Alnylam Pharmaceuticals
ALNY
#647
Rank
NZ$50.95 B
Marketcap
$393.70
Share price
0.89%
Change (1 day)
57.34%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: NZ$50.95 Billion

As of April 2025 Alnylam Pharmaceuticals has a market cap of NZ$50.95 Billion. This makes Alnylam Pharmaceuticals the world's 647th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$50.95 B-6.37%
2024NZ$54.42 B43.28%
2023NZ$37.98 B-17.52%
2022NZ$46.05 B55.09%
2021NZ$29.69 B41.89%
2020NZ$20.92 B9.08%
2019NZ$19.18 B74.45%
2018NZ$10.99 B-38.01%
2017NZ$17.74 B282.49%
2016NZ$4.63 B-60.37%
2015NZ$11.70 B22.46%
2014NZ$9.55 B91.63%
2013NZ$4.98 B328.31%
2012NZ$1.16 B160.99%
2011NZ$0.44 B-17.55%
2010NZ$0.54 B-46.68%
2009NZ$1.01 B-42.49%
2008NZ$1.76 B14.01%
2007NZ$1.54 B37.54%
2006NZ$1.12 B198.59%
2005NZ$0.37 B86.71%
2004NZ$0.20 B

End of Day market cap according to different sources

On Apr 15th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

NZ$50.51 Billion
by Nasdaq info icon info icon
NZ$50.50 Billion
by CompaniesMarketCap info icon info icon
NZ$50.50 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$2.65 B-94.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$102.11 B 100.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$8.85 B-82.63%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.92 B-96.23%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.21 B-99.57%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$369.83 B 625.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$216.90 B 325.67%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$26.07 B-48.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel